Filtered By:
Cancer: Leukemia
Countries: China Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 22 results found since Jan 2013.
Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis
CONCLUSION: This study demonstrated that hematologic cancer patients were more susceptible to a severe COVID-19 than patients without blood cancer. Thus, the management of COVID-19 in these patients requires much more attention, and their screening should perform regularly.PMID:35385130 | DOI:10.1002/jcla.24387
Source: Clinical Lymphoma and Myeloma - April 6, 2022 Category: Cancer & Oncology Authors: Adel Naimi Ilya Yashmi Reza Jebeleh Mohammad Imani Mofrad Shakiba Azimian Abhar Yasaman Jannesar Mohsen Heidary Reza Pakzad Source Type: research
Arsenic in medicine: past, present and future
Biometals. 2022 Feb 21:1-19. doi: 10.1007/s10534-022-00371-y. Online ahead of print.ABSTRACTArsenicals are one of the oldest treatments for a variety of human disorders. Although infamous for its toxicity, arsenic is paradoxically a therapeutic agent that has been used since ancient times for the treatment of multiple diseases. The use of most arsenic-based drugs was abandoned with the discovery of antibiotics in the 1940s, but a few remained in use such as those for the treatment of trypanosomiasis. In the 1970s, arsenic trioxide, the active ingredient in a traditional Chinese medicine, was shown to produce dramatic remis...
Source: Biometals - February 22, 2022 Category: Biochemistry Authors: Ngozi P Paul Adriana E Galv án Kunie Yoshinaga-Sakurai Barry P Rosen Masafumi Yoshinaga Source Type: research
Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review
The WHO announced coronavirus disease 2019 (COVID-19) as a pandemic disease globally on March 11, 2020, after it emerged in China. The emergence of COVID-19 has lasted over a year, and despite promising vaccine reports that have been produced, we still have a long way to go until such remedies are accessible to everyone. The immunomodulatory strategy has been kept at the top priority for the research agenda for COVID-19. Corticosteroids have been used to modulate the immune response in a wide range of diseases for the last 70 years. These drugs have been shown to avoid and reduce inflammation in tissues and the bloodstream...
Source: Frontiers in Microbiology - February 15, 2022 Category: Microbiology Source Type: research
In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation
ConclusionNatural products or their derivatives may be one of the potential targets to fight against SARS-CoV-2.
Source: Chinese Journal of Integrative Medicine - December 15, 2021 Category: Internal Medicine Source Type: research
Molecular epidemiology of type I and II feline coronavirus from cats with suspected feline infectious peritonitis in China between 2019 and 2021
In this study, 120 ascitic fluid samples from FIP-suspected cats were collected from veterinary hospitals in 21 provinces in China between 2019 and 2021. One hundred nine samples were positive for feline coronavirus (FCoV), with no feline immunodeficiency virus infections and one feline leukemia virus infection (1/109, 0.92%). The prevalence of FCoV was significantly associated with age (p< 0.01) and was not highly associated with gender, breed, geographical location, or viral coinfection (p> 0.01). One unique strain, SD/202012/003, contained a six-nucleotide deletion in the spike gene. Sequence analysis showed that ...
Source: Archives of Virology - November 5, 2021 Category: Virology Source Type: research
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
This article aims to give an overview on pathogenesis and risk of infectious complications in patients with CLL. In this context, we discuss current data of SARS-CoV-2 infections in patients with CLL and how the pandemic impacts their management.PMID:33631756 | DOI:10.1159/000514071
Source: Acta Haematologica - February 25, 2021 Category: Hematology Authors: Petra Langerbeins Barbara Eichhorst Source Type: research
